Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Population Pharmacokinetic,Machine Learning and Deep Learning Modelling to Predict Dosing for the Individualization of Cyclosporine Therapy in Transplant Recipients

NCT07695571 is registered in ClinicalTrials.gov with Yasmin medhat munir Mohamed as lead sponsor.

NCT NCT07695571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07695571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Population Pharmacokinetic,Machine Learning and Deep Learning Modelling to Predict Dosing for the Individualization of Cyclosporine Therapy in Transplant Recipients
Lead sponsor
Yasmin medhat munir Mohamed
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
June 1, 2027
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aml, bone marrow transplantation